Skip to main content

Advertisement

Log in

Twelve-year follow-up of penetrating keratoplasty

  • Clinical Investigation
  • Published:
Japanese Journal of Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To evaluate the long-term outcomes of penetrating keratoplasty (PKP) according to the corneal disease diagnosis and the number of PKP procedures performed.

Methods

Five-hundred-and-nine eyes from 403 patients who underwent PKP at Miyata Eye Hospital in Japan from 1998 through 2014, were included in this study. Medical charts were retrospectively examined to ascertain the corneal disease diagnosis and the period of graft survival. Graft survival rates were compared among various corneal disease diagnoses and among the number of PKP procedures performed. Changes in corneal endothelial cell density (ECD) were analyzed using a mixed-effects model. The presence/absence of various risk factors was compared between transparent grafts and failed grafts.

Results

The overall rate of graft survival at 12 years was 60.4%. The rates of graft survival in keratoconus was 100%, in corneal dystrophy 100%, in leukoma 70.8%, and in bullous keratopathy 51.7%. The rates of graft survival at 12 years for the first PKP was 65.4% and for the second PKP, 43.4% (p < 0.001). All cases of third PKP and fourth PKP failed within 8 years. Preoperative mean ECD (95% confidence interval) was 2722 (2666–2778) cells/mm2; it decreased exponentially after PKP. Mean ECD was 659 (440–878) cells/mm2 at 10 years. Rejection, trauma, and infection occurred significantly more frequently in failed grafts than in transparent grafts.

Conclusions

The long-term prognosis of PKP depends on the original diagnosis. The long-term prognosis of re-grafting is worse than that of primary grafts. Rejection, trauma, and infection are risk factors for graft failure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Thompson RW Jr, Price MO, Bowers PJ, Price FW Jr. Long-term graft survival after penetrating keratoplasty. Ophthalmology. 2003;10:1396–402.

    Article  Google Scholar 

  2. Ing JJ, Ing HH, Nelson LR, Hodge DO, Bourne WM. Ten-year postoperative results of penetrating keratoplasty. Ophthalmology. 1998;105:1855–65.

    Article  CAS  PubMed  Google Scholar 

  3. Patel SV, Hodge DO, Bourne WM. Corneal endothelium and postoperative outcomes 15 years after penetrating keratoplasty. Am J Ophthalmol. 2005;139:311–9.

    Article  PubMed  Google Scholar 

  4. Muraine M, Sanchez C, Watt L, Retout A, Brasseur G. Long-term results of penetrating keratoplasty. A 10-year-plus retrospective study. Graefes Arch Clin Exp Ophthalmol. 2003;241:571–6.

    Article  PubMed  Google Scholar 

  5. Writing Committee for the Cornea Donor Study Research Group. Factors associated with corneal graft survival in the cornea donor study. JAMA Ophthalmol. 2015;133:246–54.

    Article  Google Scholar 

  6. Tan DT, Janardhanan P, Zhou H, Chan YH, Htoon HM, Ang LP, et al. Penetrating keratoplasty in Asian eyes: the Singapore corneal transplant study. Ophthalmology. 2008;115:975–82.

    Article  PubMed  Google Scholar 

  7. Inoue K, Amano S, Oshika T, Sawa M, Tsuru T. A 10-year review of penetrating keratoplasty. Jpn J Ophthalmol. 2000;44:139–45.

    Article  CAS  PubMed  Google Scholar 

  8. Tsuchida H, Arakaki Y, Uchiyama S, Ikehara M, Kobayashi K, Yuguchi T, et al. Outcome of primary penetrating keratoplasty at Kaiya Eye Clinic. Rinsho Ganka (in Japanese). 2007;61:81–6.

    Google Scholar 

  9. Yamamoto S, Shimmura-Tomita M, Satake Y, Shimazaki-Den S, Shimmura S, Shimazaki J. Factors affecting outcomes of repeated penetrating keratoplasty. Nippon Ganka Gakkai Zasshi (in Japanese). 2015;119:625–31.

    Google Scholar 

  10. Al-Mezaine H, Wagoner MD. Repeat penetrating keratoplasty: indications, graft survival, and visual outcome. Br J Ophthalmol. 2006;90:324–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Weisbrod DJ, Sit M, Naor J, Slomovic AR. Outcomes of repeat penetrating keratoplasty and risk factors for graft failure. Cornea. 2003;22:429–34.

    Article  PubMed  Google Scholar 

  12. Yu AL, Kaiser M, Schaumberger M, Messmer E, Kook D, Welge-Lussen U. Perioperative and postoperative risk factors for corneal graft failure. Clin Ophthalmol. 2014;8:1641–7.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Vajpayee RB, Boral SK, Dada T, Murthy GVS, Pandey RM, Satpathy G. Risk factors for graft infection in India: a case-control study. Br J Ophthalmol. 2002;86:261–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Vajpayee RB, Sharma N, Sinha R, Agarwal T, Singhvi A. Infectious keratitis following keratoplasty. Surv Ophthalmol. 2007;52:1–12.

    Article  PubMed  Google Scholar 

  15. Moorthy S, Graue E, Jhanji V, Constantinou M, Vajpayee RB. Microbial keratitis after penetrating keratoplasty: impact of sutures. Am J Ophthalmol. 2011;152:189–94.

    Article  PubMed  Google Scholar 

  16. Shimazaki J, Shinozaki N, Shimmura S, Holland EJ, Tsubota K. Efficacy and safety of international donor sharing: a single-center, case-controlled study on corneal transplantation. Transplantation. 2004;78:216–20.

    Article  PubMed  Google Scholar 

  17. Inoue K, Kimura C, Amano S, Sato T, Fujita N, Kagaya F, et al. Long-term outcome of systemic cyclosporine treatment following penetrating keratoplasty. Jpn J Ophthalmol. 2001;45:378–82.

    Article  CAS  PubMed  Google Scholar 

  18. Birnbaum F, Mayweg S, Reis A, Böhringer D, Seitz B, Engelmann K, et al. Mycophenolate mofetil (MMF) following penetrating high-risk keratoplasty: long-term results of a prospective, randomised, multicentre study. Eye (Lond). 2009;23:2063–70.

    Article  CAS  Google Scholar 

  19. Reinhard T, Mayweg S, Sokolovska Y, Seitz B, Mittelviefhaus H, Engelmann K, et al. Systemic mycophenolate mofetil avoids immune reactions in penetrating high-risk keratoplasty: preliminary results of an ongoing prospectively randomized multicentre study. Transpl Int. 2005;18:703–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to thank Dr. Toshihito Furukawa (Biostatistical Research CO., LTD) for statistical analyses and Editage (http://www.editage.jp) for English language editing.

Conflicts of interest

T. Ono, None; S. Ishiyama, None; T. Hayashidera, None; Y. Mori, Grants (Alcon, AMO, BD, HOYA, Mitsubishi Chemical Medience, Otsuka pharmaceutical, Santen pharmaceutical, Senju pharmaceutical), Lecture fees (HOYA, Otsuka pharmaceutical, Pfizer, Senju pharmaceutical); R. Nejima, None; K. Miyata, Grants (Alcon, AMO, HOYA, Otsuka Pharmaceutical, Santen Pharmaceutical, Senju Pharmaceutical), Lecture fees (Alcon, AMO, Chuo Sangio, HOYA, Otsuka Pharmaceutical, Senju Pharmaceutical); S. Amano, Grants (Alcon, AMO, HOYA, Otsuka Pharmaceutical, Santen Pharmaceutical, Senju Pharmaceutical), Lecture fees (Alcon, AMO, HOYA, Otsuka Pharmaceutical, Santen Pharmaceutical, Senju Pharmaceutical).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shiro Amano.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ono, T., Ishiyama, S., Hayashidera, T. et al. Twelve-year follow-up of penetrating keratoplasty. Jpn J Ophthalmol 61, 131–136 (2017). https://doi.org/10.1007/s10384-016-0489-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10384-016-0489-2

Keywords

Navigation